Kaydan Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$249K Buy
215
+16
+8% +$18.9K 0.09% 103
2026
Q2
$239K Buy
+199
New +$203K 0.07% 111

Other funds holding LLY

Kaydan Wealth Management's LLY Position: Q3 2026 in Review

Kaydan Wealth Management increased its Eli Lilly (LLY) stake by 8% in Q3 2026, buying an estimated $18.9K and bringing the position to 215 shares worth $249K. The position accounts for 0.09% of the portfolio, ranked #103.

Kaydan Wealth Management first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Kaydan Wealth Management held 215 shares of Eli Lilly worth $249K as of Q3 2026.
  • Kaydan Wealth Management bought 16 Eli Lilly shares in Q3 2026, an estimated $18.9K.
  • Eli Lilly made up 0.09% of Kaydan Wealth Management's portfolio in Q3 2026, its #103 holding.
  • Kaydan Wealth Management first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Kaydan Wealth Management's 13F filing for Q3 2026, filed 8 Oct 2026.